Background: Mechanistic studies suggests that mitochondria DNA (mtDNA) dysfunction may be associated with increased risk of atrial fibrillation (AF). The association between mtDNA copy number (mtDNA-CN) and incident AF in the general population, however, remains unknown.
In CHS, AF cases were identified through December 31, 2012 from three sources: annual ECGs 1 0 0 at each study visit through 1999, discharge diagnoses for all hospitalizations (ICD-9-CM code 427.31 or 1 0 1 427.32), and for those enrolled in fee-for-service Medicare, from inpatient, outpatient or physician The measurement of other covariates in the three cohorts has been described previously. [19] [20] [21] 1 0 8
Age, sex, race/ethnicity, alcohol intake, smoking status, physical activity and medication use were self-1 0 9
reported. Alcohol consumption was categorized into never, former, and current for ARIC and MESA, 1 1 0 and into non-current and current for CHS. Body mass index was calculated as weight (kilograms) Time Physical Activity Questionnaire in CHS (scale 1-4), and as the total amount of intentional 1 1 5 moderate or vigorous exercise performed in a usual week in MESA (MET-min/week). Prevalent heart 1 1 6 failure was defined by hospital records, physician diagnosis, or self-reported history of treatment. Plasma total cholesterol, HDL cholesterol, fasting glucose, and creatinine were measured in each 1 1 8 study are previously described. [19] [20] [21] N-terminal pro-brain natriuretic peptide (NT-proBNP) was 1 1 9 measured at visit 2 and 4 using an electrochemiluminescent immunoassay in ARIC, and at baseline Follow-up started from the baseline visit and continued until development of AF, death, dropout, 1 2 8 or through December 31, 2014 in ARIC and MESA or December 31, 2012 in CHS, whichever occurred 1 2 9
first. mtDNA-CN was categorized into cohort-specific quintiles. We used a Cox proportional hazards 1 3 0 model to estimate hazard ratios (HR) and 95% confidence intervals (CI) for the association between 1 3 1 mtDNA-CN and incident AF in each cohort. HRs compared quintiles 1 st -4 th with the 5 th quintile 1 3 2 (reference). Linear trends across quintiles were tested by including a variable containing the median 1 3 3 mtDNA-CN level of each quintile in the models. We also modeled mtDNA-CN as a continuous variable 1 3 4 and estimated the HR comparing the 10 th to the 90 th percentile of mtDNA-CN. In addition, to evaluate 1 3 5 non-linear dose-response relationships between mtDNA-CN and incident AF, we modeled mtDNA-CN 1 3 6 as restricted cubic splines with knots at the 5 th , 35 th , 65 th , and 95 th percentiles of its distribution. Finally, 1 3 7
we tested for potential interactions by age, sex, race, smoking, alcohol intake, BMI, hypertension, 1 3 8 diabetes, and kidney disease. All analyses were conducted separately in each cohort and cohort-specific HRs were combined 1 4 0 using a fixed-effects meta-analysis approach. In each cohort, we used 4 multivariate models with 1 4 1 progressive degrees of adjustment. Model 1 was adjusted for age, sex, and race-enrollment center groups. Model 2 was further adjusted for body mass index, height, smoking, alcohol intake, and physical activity. Model 3 was further adjusted for total and HDL cholesterol, cholesterol medication, hypertension, The study included 19,709 participants total (10,149 from ARIC, 5,781 from MESA, and 3,779 1 5 1 from CHS). The mean (standard deviation) age of study participants was 57.2 (5.9), 62.3 (10.3), and In three large population-based prospective cohort studies, mtDNA-CN was inversely associated 1 7 1 with the risk of incident AF, independent of traditional risk factors. The association was not statistically 1 7 2 different across race and sex groups. This novel association indicates a potential role of mitochondrial 1 7 3 dysfunction in atrial arrhythmias, and adds to the pathophysiological evidence from basic science studies 1 7 4 supporting a role of mitochondrial mechanisms in the genesis of AF. Animal models and molecular studies suggest that mitochondrial dysfunction is associated with 1 7 6 adverse CVD outcomes and subclinical atherosclerosis, [29, 30] and some of these associations have 1 7 7 been confirmed in population-based studies. In ARIC, MESA, and CHS, low levels of mtDNA-CN were 1 7 8 associated with increased risk of incident CVD, coronary heart disease, sudden cardiac death, and all- CVD risk factors are also risk factors for AF, the inverse associations between mtDNA-CN and AF 1 8 2 could also be mediated through the traditional CVD pathways. As participants in our analysis were free 1 8 3 of CHD at baseline and we adjusted for CVD risk factors, our findings suggest that CVD and traditional 1 8 4 risk factors do not fully explain the association between mtDNA-CN and incident AF. Furthermore, 1 8 5 since low mtDNA-CN levels preceded the development of AF and other CVD events in ARIC, CHS, 1 8 6 and MESA, maintaining CVD health may require adequate cell energy mechanisms and mitochondrial 1 8 7 function for preserved cardiac contractility, electrical activity, and endothelial function. myocardium, which in turn adversely affect cardiac function and increase the risk of mortality, stroke, diabetes, obesity and smoking). [25, 32, 33] Our results suggest that mtDNA-CN may be a novel risk 1 9 3 factor for AF. As low levels of mtDNA-CN are a marker for mitochondrial dysfunction and abnormal 1 9 4 ATP production, our findings suggest that myocyte electrical activity could be compromised by 1 9 5 mitochondrial dysfunction and insufficient energy supply. The mechanisms underlying the association between mtDNA-CN and AF are unknown, but 1 9 7 previous mechanistic research and in-vitro studies provide some leads. Most of the energy for 1 9 8 cardiomyocyte electrical activity and cardiac muscle contraction is supplied by mitochondria through the coupling. Indeed, disrupted intracellular Ca 2+ homeostasis has been shown to contribute to the 2 0 3 pathogenesis of AF. [17, 18, 34] Increased ROS can also impair gap junction regulation and affect 2 0 4 voltage-gated sodium potassium channels, which increases electrical heterogeneity and cause early mtDNA-CN and incident AF was consistent in ARIC, CHS, and MESA, adding weight to the validity of 2 1 6 our findings. mtDNA-CN was collected from peripheral blood, and was thus not a direct measurement 2 1 7 of mitochondrial function in atrial myocytes. However, mtDNA from peripheral blood has been shown 2 1 8 to be strongly correlated with mtDNA from cardiomyocyte (coefficient of correlation >0.5). [13, 36] Therefore, the mtDNA-CN from peripheral blood could be used a marker for myocardial mitochondrial 2 2 0 function. Furthermore, mtDNA-CN was measured only at single time-point, and variability due to 2 2 1 changes over time was not captured. Finally, we could not evaluate the association between mtDNA-CN 2 2 2 with various subtypes of AF. Since AF was obtained primarily based on hospital discharge codes in all 3 2 2 3 studies, the diagnoses were mostly persistent or permanent forms of AF, whereas asymptomatic 2 2 4 paroxysmal AF, the most common type of AF, is often undetected. Future studies with repeated and its impact on AF risk. The strengths of this study include the prospective design, the long follow-up, the rigorous 2 2 8 quality control procedures of the individual cohorts, the large sample size, and the heterogeneous 2 2 9 composition of the study population, including men and women from multiple race / ethnicity groups 2 3 0 and a wide age range from middle-aged adults to elderly participants. In conclusion, in three prospective community-based cohorts, mtDNA-CN levels in peripheral 2 3 2 blood were inversely associated with the risk of AF independent of traditional risk factors. These understand the underlying mechanisms, to better characterize the dose-response shape of the association, 2 3 5 and to evaluate the role of mtDNA-CN in the prevention and management of AF risk. F  u  s  t  e  r  V  ,  R  y  d  e  n  L  E  ,  C  a  n  n  o  m  D  S  ,  C  r  i  j  n  s  H  J  ,  C  u  r  t  i  s  A  B  ,  E  l  l  e  n  b  o  g  e  n  K  A  ,  H  a  l  p  e  r  i  n  J  L  ,  K  a  y  G  N  ,  L  e  H  u  e  z  e  y  J  Y  ,  2  4 3  3  2  3  5  .  B  r  o  w  n  D  A  ,  O  '  R  o  u  r  k  e  B  :   C  a  r  d  i  a  c  m  i  t  o  c  h  o  n  d  r  i  a  a  n  d  a  r  r  h  y  t  h  m  i  a  s   .  C  a  r  d  i  o  v  a  s  c  R  e  s  2  0  1  0  ,   8  8   (  2  )  :  2  4  1  -2  4  9  .  3  3  3   3  6  .  K  n  e  z  J  ,  L  a  k  o  t  a  K  ,  B  o  z  i  c  N  ,  O  k  r  a  j  s  e  k  R  ,  C  a  u  w  e  n  b  e  r  g  h  s  N  ,  T  h  i  j  s  L  ,  K  n  e  z  e  v  i  c  I  ,  V  r  t  o  v  e  c  B  ,  T  o  m  s  i  c  M  ,  C  u  c  n  i  k  S  3  3  4   e  t  a  l  :   C  o  r  r  e  l  a  t  i  o  n  B  e  t  w  e  e  n  M  i  t  o  c  h  o  n  d  r  i  a  l  D  N  A  C  o  n  t  e  n  t  M  e  a  s  u  r  e  d  i  n  M  y  o  c  a  r  d  i  u  m  a  n  d  P  e  r  i  p  h  e  r  a  l   3  3  5   B  l  o  o  d  o  f  P  a  t  i  e  n  t  s  w  i  t  h  N  o  n  -I  s  c  h  e  m  i  c  H  e  a  r  t  F  a  i  l  u  r  e   .  G  e  n  e  t  T  e  s  t  M  o  l  B  i  o  m  a  r  k  e  r  s  2  0  1  7  ,   2  1   (  1  2  )  :  7  3  6  -7  4  1  .  3  3  6 3 3 7 The figure includes hazard ratios for comparing quintiles 1 st -4 th with the 5 th quintile (reference) of 3 4 2 mtDNA copy number, as well as the hazard ratio for coparing the 10 th to the 90 th percentile of mtDNA 3 4 3 copy number. Models were adjusted for age, sex, race/enrollment center, body mass index, height, The curves represent adjusted hazard ratios (solid line) and their 95% confidence intervals (dashed lines) 3 5 0 based on restricted cubic splines of mtDNA copy number with knots at the 5 th , 35 th , 65 th and 95 th 3 5 1 percentiles of its distribution. The reference value (diamond dot) was set at the 90 th percentile of the 3 5 2 distribution. Models were adjusted for age, sex, race/enrollment center, body mass index, height, 3 5 3 smoking, alcohol intake, physical activity, total and HDL cholesterol, cholesterol medication, 3 5 4 hypertension, diabetes, prevalent CHD, prevalent heart failure, eGFR and log-transformed NT-proBNP 3 5 5 at baseline. Histograms represent the frequency distribution of mtDNA copy number at baseline. 1.26 (1.09, 1.46)  1.21 (1.05, 1.40)  1.20 (1.04, 1.39 .20 (1.07, 1.34)  1.18 (1.05, 1.31)  1.16 (1.04, 1.30)  1.18 (1.04, 1.33 .19 (1.01,1.39)  1.18 (1.00,1.39 .18 (1.07, 1.30)  1.15 (1.05, 1.27)  1.13 (1.02, 1.25)  1.13 (1.01, 1.27 07 (0.97, 1.18)  1.13 (1.01, 1.27 .12 (1.01, 1.23)  1.11 (1.00, 1.22 .14 (1.06, 1.23)  1.13 (1.04, 1.22)  1.11 (1.03, 1.20)  1.13 (1.04, 1.24 
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